PROGRAMMED CELL DEATH IN LYMPHOCYTES
PROGRAMMED CELL DEATH IN LYMPHOCYTES
批准号:
2463763
负责人:
P A HENKART
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
中文摘要
本课题研究了T淋巴细胞程序化细胞的两个方面
英文摘要
This project has examined two aspects of T lymphocyte programmed cell
death: (1)The roles of calpain and reactive oxygen intermediates in the
TcR-triggered events in the "activation-induced" death of mature T
cells, which involves TcR-induced Fas ligand upregulation and
subsequent Fas crosslinking; (2) the role of ICE-family proteases
(caspases) as common downstream mediators of multiple pathways of
apoptotic death in all stages of T lymphocyte development. Previous
results had shown that the TcR-induced death pathway in hybridomas and
blasts is blocked by both protease inhibitors and antioxidants, and we
have continued to define the mechanisms of these inhibitions. Specific
inhibitors of the calcium-dependent cysteine protease calpain
selectively blocked TcR induced FasL mRNA upregulation. These
inhibitors blocked activation-induced FasL promoter activity as
assessed by transfection with a luciferase reporter construct.
Antioxidants behave like calpain inhibitors in that most block the
TcR-induced Fas ligand upregulation at the mRNA transcription level.
Activation-induced reactive oxygen intermediates were detected in
hybridomas by dihydrorhodamine oxidation as detected by flow cytometry.
We have addressed the role of ICE-family proteases (caspases) as
downstream mediators of apoptotic death in T lymphocytes by testing the
ability of caspase inhibitors to block death in various T cells induced
by different stimuli. We have principally used the
peptide-fluoromethyl ketone caspase inhibitors ZVAD-FMK (an inhibitor
of ICE and CPP32) and BD-FMK (an inhibitor of CPP32 but not ICE). Both
compounds completely and specifically block all readouts of thymocyte
death by four independent pathways. When resting peripheral T cells
were examined, ZVAD-FMK was somewhat less effective than BD-FMK, while
with T cell blasts, ZVAD-FMK was considerably less potent an inhibitor
than BD-FMK. The apoptotic death of CTLL-2 cells was inhibited by
BD-FMK but not by ZVAD-FMK. These results argue that caspases do play
a critical functional role in all T cell apoptotic death, but the
differential sensitivity to these inhibitors suggests that different
caspase family members are critical in different T cells and stimuli.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
APOPTOTIC DEATH IN T LYMPHOCYTES
-
批准号:6100954
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:P A HENKART
-
依托单位:
TARGET CELL DAMAGE BY IMMUNE MECHANISMS
-
批准号:6161048
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:P A HENKART
-
依托单位:
PROGRAMMED CELL DEATH IN LYMPHOCYTES
-
批准号:3774389
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:P A HENKART
-
依托单位:
TARGET CELL DAMAGE BY IMMUNE MECHANISMS
-
批准号:3796537
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:P A HENKART
-
依托单位:
PROGRAMMED CELL DEATH IN LYMPHOCYTES
-
批准号:3752092
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:P A HENKART
-
依托单位:
TARGET CELL DAMAGE BY IMMUNE MECHANISMS
-
批准号:3916398
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:P A HENKART
-
依托单位:
STRUCTURE AND FUNCTION OF CYTOTOXIC AND HELPER T LYMPHOCYTE GRANULES
-
批准号:3916408
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:P A HENKART
-
依托单位:
TARGET CELL DAMAGE BY IMMUNE MECHANISMS
-
批准号:3813453
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:P A HENKART
-
依托单位:
PROGRAMMED CELL DEATH IN LYMPHOCYTES
-
批准号:3796542
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:P A HENKART
-
依托单位:
MEMBRANE DAMAGE BY IMMUNE MECHANISMS
-
批准号:3962935
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:P A HENKART
-
依托单位:
APOPTOTIC DEATH IN T LYMPHOCYTES
-
批准号:6161054
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:P A HENKART
-
依托单位:
MEMBRANE DAMAGE BY IMMUNE MECHANISMS
-
批准号:4691749
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:P A HENKART
-
依托单位:
STRUCTURE AND FUNCTION OF CYTOTOXIC T LYMPHOCYTE GRANULES
-
批准号:3939239
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:P A HENKART
-
依托单位:
PROGRAMMED CELL DEATH IN LYMPHOCYTES
-
批准号:5201007
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:P A HENKART
-
依托单位:
TARGET CELL DAMAGE BY IMMUNE MECHANISMS
-
批准号:5201003
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:P A HENKART
-
依托单位:
TARGET CELL DAMAGE BY IMMUNE MECHANISMS
-
批准号:3774385
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:P A HENKART
-
依托单位:
TARGET CELL DAMAGE BY IMMUNE MECHANISMS
-
批准号:6100948
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:P A HENKART
-
依托单位:
STRUCTURE AND FUNCTION OF CYTOTOXIC T LYMPHOCYTE GRANULES
-
批准号:4691768
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:P A HENKART
-
依托单位:
TARGET CELL DAMAGE BY IMMUNE MECHANISMS
-
批准号:3808591
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:P A HENKART
-
依托单位:
STRUCTURE AND FUNCTION OF CYTOTOXIC T LYMPHOCYTE GRANULES
-
批准号:3962951
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:P A HENKART
-
依托单位:
海外基金